ARCT

Arcturus Therape

• TipRanks·1d ago

  Roth MKM Remains a Buy on Arcturus Therapeutics (ARCT)

• Seeking Alpha·3d ago

  Cathie Wood's ARK boosts Palantir, Tesla, Roninhood bets; cuts semiconductor exposure

• TipRanks·6d ago

  Cathie Wood Buys the Dip in GeneDx (WGS): 142% Upside Ahead

• Seeking Alpha·04/06 11:39

  Cathie Wood's weekly moves signal shift to AI, precision medicine

• Seeking Alpha·03/31 10:35

  Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names

• TipRanks·03/26 22:55

  Roth MKM Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)

• Reuters·03/18 12:03

  ARCTURUS THERAPEUTICS HOLDINGS INC <ARCT.O>: B. RILEY INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $22

• Dow Jones·03/18 10:56

  Arcturus Therapeutics Price Target Announced at $22.00/Share by B. Riley Securities

• TipRanks·03/18 09:05

  Arcturus Therapeutics initiated with a Buy at B. Riley

• Reuters·03/18 07:36

  U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

• Seeking Alpha·03/06 21:04

  Arcturus Therapeutics: Downgrading To "Hold" As CF Program Shifts Population Focus

• Dow Jones·03/05 20:34

  Arcturus Therapeutics Price Target Cut to $21.00/Share From $66.00 by Citigroup

• Dow Jones·03/05 20:34

  Arcturus Therapeutics Is Maintained at Buy by Citigroup

• Reuters·03/05 14:01

  Arcturus Therapeutics to Join Leerink Partners 2026 Global Healthcare Conference Fireside Chat

• TipRanks·03/05 11:25

  Arcturus Therapeutics price target lowered to $21 from $66 at Canaccord